Avanthi Pharma
Home Contact Us
Home Contact Us
HomeAbout UsNewsGeneric DrugsProductsContact Us
Avanthi Pharma
Chlorphen-12 now available at Drugstore.com
now available at Drugstore.com
Click here to order


December 22, 2010 Diethylpropion HCl Tablets (25 mg) Approved by the FDA

August 31, 2009
Oxycodone HCl Tablets USP (5mg, 10mg, 15mg, 20mg, 30mg AB rated) Approved by the FDA

May 12, 2009
Chlorpheniramine Maleate, Extended - Release Tablets (12 mg) Approved by the FDA

March 6, 2009
Indomethacin, Extended - Release Capsules USP (75 mg) Approved by the FDA


Avanthi, Inc. develops high quality prescription and OTC pharmaceuticals in the United States.

The company is committed to developing various dosage forms that include immediate and modified release tablets, capsules, liquids and semisolid dosage forms. Our products are available throughout the United States from pharmaceutical wholesalers, distributors, chain drug stores and managed care organizations.

The business environment in which Avanthi, Inc. participates is dynamic. External factors such as population demographics and healthcare funding/expenditures continue to present new challenges. The organization is dedicated to meeting the present and future needs of the healthcare marketplace. Correspondingly, it has allocated substantial resources to aggressively pursue the development of off-patent pharmaceutical products and new modified release products. The company’s employees are devoted to the application of sound scientific fundamentals and make a worthwhile contribution to the well being of consumers.